|
1
|
Chopra A, Soni S, Verma D, Kumar D,
Dwivedi R, Vishwanathan A, Vishwakama G, Bakhshi S, Seth R, Gogia
A, et al: Prevalence of common fusion transcripts in acute
lymphoblastic leukemia: A report of 304 cases. Asia Pac J Clin
Oncol. 11:293–298. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Durinck K, Goossens S, Peirs S, Wallaert
A, Van Loocke W, Matthijssens F, Pieters T, Milani G, Lammens T,
Rondou P, et al: Novel biological insights in T-cell acute
lymphoblastic leukemia. Exp Hematol. 43:625–639. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
D'Angelo V, Iannotta A, Ramaglia M,
Lombardi A, Zarone MR, Desiderio V, Affinita MC, Pecoraro G, Di
Martino M, Indolfi P, et al: EZH2 is increased in paediatric T-cell
acute lymphoblastic leukemia and is a suitable molecular target in
combination treatment approaches. J Exp Clin Cancer Res. 34:832015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Akahane K, Sanda T, Mansour MR, Radimerski
T, DeAngelo DJ, Weinstock DM and Look AT: HSP90 inhibition leads to
degradation of the TYK2 kinase and apoptotic cell death in T-cell
acute lymphoblastic leukemia. Leukemia. 30:219–228. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen KH, Liao AC, Hung JH, Lee WJ, Hu KC,
Lin PT, Liao RF and Chen PS: α-solanine inhibits invasion of human
prostate cancer cell by suppressing epithelial-mesenchymal
transition and MMPs expression. Molecules. 19:11896–11914. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu MK, Shih YW, Chien Chang TT, Fang LH,
Huang HC and Chen PS: α-solanine inhibits human melanoma cell
migration and invasion by reducing matrix metalloproteinase-2/9
activities. Biol Pharm Bull. 33:1685–1691. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kenny OM, McCarthy CM, Brunton NP, Hossain
MB, Rai DK, Collins SG, Jones PW, Maguire AR and O'Brien NM:
Anti-inflammatory properties of potato glycoalkaloids in stimulated
Jurkat and Raw 264.7 mouse macrophages. Life Sci. 92:775–782. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lv C, Kong H, Dong G, Liu L, Tong K, Sun
H, Chen B, Zhang C and Zhou M: Antitumor efficacy of α-solanine
against pancreatic cancer in vitro and in vivo. PLoS One.
9:e878682014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun H, Lv C, Yang L, Wang Y, Zhang Q, Yu
S, Kong H, Wang M, Xie J, Zhang C and Zhou M: Solanine induces
mitochondria-mediated apoptosis in human pancreatic cancer cells.
Biomed Res Int. 2014:8059262014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao SY, Wang QJ and Ji YB: Effect of
solanine on the membrane potential of mitochondria in HepG2 cells
and [Ca2+]i in the cells. World J Gastroenterol. 12:3359–3367.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ji YB, Gao SY, Ji CF and Zou X: Induction
of apoptosis in HepG2 cells by solanine and Bcl-2 protein. J
Ethnopharmacol. 115:194–202. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Friedman M: Chemistry and anticarcinogenic
mechanisms of glycoalkaloids produced by eggplants, potatoes, and
tomatoes. J Agric Food Chem. 63:3323–3337. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Friedman M, Lee KR, Kim HJ, Lee IS and
Kozukue N: Anticarcinogenic effects of glycoalkaloids from potatoes
against human cervical, liver, lymphoma, and stomach cancer cells.
J Agric Food Chem. 53:6162–6169. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kwak CH, Lee SH, Lee SK, Ha SH, Suh SJ,
Kwon KM, Chung TW, Ha KT, Chang YC, Lee YC, et al: Induction of
apoptosis and antitumor activity of eel skin mucus, containing
lactose-binding molecules, on human leukemic K562 cells. Mar Drugs.
13:3936–3949. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Scarfò L and Ghia P: Reprogramming cell
death: BCL2 family inhibition in hematological malignancies.
Immunol Lett. 155:36–39. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qi L, Ren K, Fang F, Zhao DH, Yang NJ and
Li Y: Over expression of BCL2 and low expression of caspase 8
related to TRAIL resistance in brain cancer stem cells. Asian Pac J
Cancer Prev. 16:4849–4852. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Christodoulou MI, Kontos CK, Halabalaki M,
Skaltsounis AL and Scorilas A: Nature promises new anticancer
agents: Interplay with the apoptosis-related BCL2 Gene Family.
Anticancer Agents Med Chim. 14:375–399. 2014. View Article : Google Scholar
|
|
19
|
Wang S, Zhou M, Ouyang J, Geng Z and Wang
Z: Tetraarsenictetrasulfide and arsenic trioxide exert synergistic
effects on induction of apoptosis and differentiation in acute
promyelocytic leukemia Cells. PLoS One. 10:e01303432015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Subburaj Y, Cosentino K, Axmann M,
Pedrueza-Villalmanzo E, Hermann E, Bleicken S, Spatz J and
García-Sáez AJ: Bax monomers form dimer units in the membrane that
further self-assemble into multiple oligomeric species
Introduction. Nat Commun. 6:80422015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cingeetham A, Vuree S, Dunna NR, Gorre M,
Nanchari SR, Edathara PM, Meka P, Annamaneni S, Digumarthi R, Sinha
S and Satti V: Influence of BCL2-938C>A and BAX-248G>A
promoter polymorphisms in the development of AML: Case-control
study from South India. Tumour Biol. 36:7967–7976. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stamati L, Avgeris M, Kosmidis H, Baka M,
Anastasiou T, Piatopoulou D, Scorilas A and Gourgiotis D:
Overexpression of BCL2 and BAX following BFM induction therapy
predicts ch-ALL patients' poor response to treatment and short-term
relapse. J Cancer Res Clin Oncol. 141:2023–2036. 2015. View Article : Google Scholar : PubMed/NCBI
|
